NCT03857373 Renal Cancer Detection Using Convolutional Neural Networks
| NCT ID | NCT03857373 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nessn Azawi |
| Condition | Kidney Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2019-02-01 |
| Primary Completion | 2025-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2019-02-01 with a primary completion date of 2025-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We aim to experiment and implement various deep learning architectures in order to achieve human-level accuracy in Computer-aided diagnosis (CAD) systems. In particular, we are interested in detecting renal tumors from CT urography scans in this project. We would like to classify renal tumor to cancer, non cancer, renal cyst I, renal cyst II, renal cyst III and renal cyst VI, with high sensitivity and low false positive rate using various types of convolutional neural networks (CNN). This task can be considered as the first step in building CAD systems for renal cancer diagnosis. Moreover, by automating this task, we can significantly reduce the time for the radiologists to create large-scale labeled datasets of CT-urography scans.
Eligibility Criteria
Inclusion Criteria: * All patient with RCC, who underwent surgery Exclusion Criteria: * Patients with RCC, who did not underwent surgery
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03857373 clinical trial?
This trial is open to participants of all sexes, studying Kidney Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03857373 currently recruiting?
Yes, NCT03857373 is actively recruiting participants. Contact the research team at nesa@regionsjaelland.dk for enrollment information.
Where is the NCT03857373 trial being conducted?
This trial is being conducted at Roskilde, Denmark.
Who is sponsoring the NCT03857373 clinical trial?
NCT03857373 is sponsored by Nessn Azawi. The trial plans to enroll 5,000 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.